473
PHASE 2 STUDY OF PEVONEDISTAT + AZACITIDINE VERSUS AZACITIDINE IN PATIENTS WITH HIGHER-RISK MYELODYSPLASTIC SYNDROMES/CHRONIC MYELOMONOCYTIC LEUKEMIA OR LOW-BLAST ACUTE MYELOGENOUS LEUKEMIA (NCT02610777)
L. Adèsa, J. Wattsb, A. Radinoffc, M.A. Sangermand, M. Cerranoe, P.F. Lopezf, J. Zeidnerg, M.D. Campeloh, C. Grauxi, J. Liesveldj, D. Selleslagk, N. Tzvetkovl, R.J. Framm, D. Zhaom, J. Bellm, S. Friedlanderm, D.V. Fallerm, M.A. Sekeresn
a Hôpital Saint-Louis, Paris, France
b Sylvester Comprehensive Cancer Center, University of Miami, Miami, United States
c University Hospital Sveti Ivan Rislki, Sofia, Bulgaria
d Institut Català d’Oncologia-Institut d’Investigació Biomèdica de Bellvitge (IDIBELL), Hospitalet, Barcelona, Spain
e Department of Molecular Biotechnology and Health Sciences, Division of Hematology, University of Turin, Turin, Italy
f Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain
g University of North Carolina, Lineberger Comprehensive Cancer Center, Chapel Hill, United States
h Department of Hematology, University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Center for Cancer Research-IBMCC (USAL-CSIC), Salamanca, Spain
i Université Catholique de Louvain, Centre Hospitalier Universitaire, Namur, Yvoir, Belgium
j The James P Wilmot Cancer Institute, University of Rochester, Rochester, United States
k AZ Sint Jan Brugge-Oostende, Brugge, Belgium
l MHAT Dr. Georgi Stranski, Clinic of Haematology, Pleven, Bulgaria
m Millennium Pharmaceuticals, Inc., Cambridge, United States, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited.
n Cleveland Clinic, Cleveland, United States
Ver másRead
2628
Timeswas read the article
1088
Total PDF
1540
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 May | 58 | 14 | 72 |
| 2025 April | 46 | 13 | 59 |
| 2025 March | 69 | 9 | 78 |
| 2025 February | 47 | 19 | 66 |
| 2025 January | 54 | 17 | 71 |
| 2024 December | 38 | 15 | 53 |
| 2024 November | 45 | 15 | 60 |
| 2024 October | 24 | 16 | 40 |
| 2024 September | 46 | 17 | 63 |
| 2024 August | 28 | 19 | 47 |
| 2024 July | 22 | 21 | 43 |
| 2024 June | 27 | 16 | 43 |
| 2024 May | 30 | 28 | 58 |
| 2024 April | 36 | 16 | 52 |
| 2024 March | 33 | 13 | 46 |
| 2024 February | 32 | 23 | 55 |
| 2024 January | 26 | 14 | 40 |
| 2023 December | 21 | 29 | 50 |
| 2023 November | 38 | 19 | 57 |
| 2023 October | 20 | 25 | 45 |
| 2023 September | 31 | 27 | 58 |
| 2023 August | 34 | 18 | 52 |
| 2023 July | 28 | 10 | 38 |
| 2023 June | 25 | 21 | 46 |
| 2023 May | 31 | 20 | 51 |
| 2023 April | 16 | 6 | 22 |
| 2023 March | 27 | 16 | 43 |
| 2023 February | 24 | 11 | 35 |
| 2023 January | 19 | 6 | 25 |
| 2022 December | 27 | 18 | 45 |
| 2022 November | 26 | 23 | 49 |
| 2022 October | 27 | 24 | 51 |
| 2022 September | 31 | 32 | 63 |
| 2022 August | 20 | 13 | 33 |
| 2022 July | 24 | 27 | 51 |
| 2022 June | 19 | 21 | 40 |
| 2022 May | 12 | 25 | 37 |
| 2022 April | 23 | 22 | 45 |
| 2022 March | 15 | 18 | 33 |
| 2022 February | 19 | 21 | 40 |
| 2022 January | 17 | 22 | 39 |
| 2021 December | 16 | 19 | 35 |
| 2021 November | 19 | 27 | 46 |
| 2021 October | 31 | 33 | 64 |
| 2021 September | 25 | 26 | 51 |
| 2021 August | 32 | 29 | 61 |
| 2021 July | 20 | 20 | 40 |
| 2021 June | 16 | 25 | 41 |
| 2021 May | 19 | 39 | 58 |
| 2021 April | 40 | 28 | 68 |
| 2021 March | 22 | 19 | 41 |
| 2021 February | 17 | 11 | 28 |
| 2021 January | 10 | 19 | 29 |
| 2020 December | 21 | 17 | 38 |
| 2020 November | 17 | 17 | 34 |
Show all
